Chester County News and Community Website
MALVERN, PA — In a significant advancement for retinitis pigmentosa (RP) treatment, Ocugen, Inc. (NASDAQ: OCGN) has received favorable scientific advice from the European Medicines Agency (EMA) regarding its pivotal …
Ocugen’s Gene Therapy OCU400 Moves Closer to European Market with EMA’s Positive Opinion Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focusing on discovering, developing, and commercializing transformative therapies to cure blindness diseases, announced a significant milestone in its Phase 1/2 …
Ocugen Advances in Pioneering Gene Therapy for Geographic Atrophy with DSMB Approval to Proceed to Medium Dose in Clinical Trial Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has granted equity awards to 30 new hires under its 2023 Inducement Plan, as a key part of the employment package designed …
Madrigal Pharmaceuticals Awards Equity to New Employees as Inducement Read More MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN released its general business update on Tuesday, revealing promising strides in the pursuit of transformative treatments for blindness diseases. The Pennsylvania-based company’s dedication …
Ocugen Inc. Embarks on A Game-Changing Era With Revolutionary Gene Therapy Initiatives Read More
BERWYN, PA — AscellaHealth has released its latest edition of the Specialty & Rare Pipeline Digest™. This quarterly digital publication stands as the industry’s most detailed resource on imminent specialty …
AscellaHealth Unveils Quarter’s Insights on Specialty and Rare Disease Drug Developments Read More
BRISTOL, PA — Abzena has unveiled a $5 million investment to enhance its Bristol, Pennsylvania facility, specializing in bioconjugate development and cGMP (current Good Manufacturing Practice) manufacturing. This substantial financial …
Abzena Amplifies Bioconjugate Development and Manufacturing with $5 Million Bristol Site Expansion Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO), a pioneer in the development of DNA medicines for treating and preventing diseases, has announced its participation in the upcoming Citizens JMP Novel …
INOVIO’s Leadership to Spotlight Innovative Disease-Fighting Technologies at Citizens JMP Novel Therapeutics Forum Read More
NEWTOWN, PA — In a market landscape dominated by titans in the biotech and healthcare technology sectors, Helius Medical Technologies, Inc. (Nasdaq: HSDT) found themselves in a David versus Goliath …
Helius Medical Technologies: Strides Towards Reimbursement for Innovative PoNS Therapy Amidst Financial Challenges Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has recently shared its financial results for the full year of 2023, accompanying these figures with a business update for …
Orchestra BioMed: Continuing the Momentum into a Promising Future Read More
PHILADELPHIA, PA — A paramount scientific breakthrough has been achieved by the combined intellectual prowess of researchers from the University of Pennsylvania (Penn), J. Craig Venter Institute (JCVI), and the …
Constructing the Path to Brave New Biotech: Single-copy Human Artificial Chromosomes Read More